Literature DB >> 90214

Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong.

R G Newman, W B Whitehill.   

Abstract

In a double-blind study carried out between 1972 and 1975 in Hong Kong 100 heroin addict volunteers were initially admitted to hospital for two weeks for stabilisation on 60 mg of methadone before being assigned at random to two groups: one group received methadone (range 30--130 mg, average 97 mg/day); those in the other group had their dose of methadone reduced at the rate of 1 mg/day and were then maintained on placebo. All subjects were provided with a broad range of supportive services. After thirty-two weeks 10% of the controls were still on treatment, compared with 76% of those receiving methadone. At the end of the three-year project, only 1 of the original 50 placebo subjects still turned up for treatment (2%), whereas the retention-rate (proportion still on treatment) for methadone subjects was 56%. Subjects who had dropped out of the study and were readmitted for methadone treatment under known conditions had the same retention-rate as the original treatment group.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90214     DOI: 10.1016/s0140-6736(79)91550-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

1.  When should we delay highly active antiretroviral therapy?

Authors:  D R Bangsberg; A Moss
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

2.  Policy progress for physician treatment of opiate addiction.

Authors:  Joseph O Merrill
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

3.  Recent developments in maintenance prescribing and monitoring in the United Kingdom.

Authors:  C Brewer
Journal:  Bull N Y Acad Med       Date:  1995

Review 4.  [Maintenance treatment of opiate addicts].

Authors:  N Scherbaum
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

5.  Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects.

Authors:  Julia Hanna; David J R Foster; Amy Salter; Andrew A Somogyi; Jason M White; Felix Bochner
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

Review 6.  A risk-benefit analysis of methadone maintenance treatment.

Authors:  J Bell; D Zador
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 7.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

Review 8.  Opiate-dependent patients receiving methadone. How physicians should manage therapy.

Authors:  M Kahan; N Sutton
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

9.  In Their Own Voices: Breaking the Vicious Cycle of Addiction, Treatment and Criminal Justice Among People who Inject Drugs in Ukraine.

Authors:  Alyona Mazhnaya; Martha J Bojko; Ruthanne Marcus; Sergii Filippovych; Zahedsul Islam; Sergey Dvoriak; Frederick L Altice
Journal:  Drugs (Abingdon Engl)       Date:  2016-02-16

Review 10.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.